$4.75M Ferring, Aventis Antitrust Settlement Earns Approval
A $4.75 million settlement that Ferring BV and Aventis Pharmaceuticals Inc. struck with indirect purchasers of an antidiuretic won approval from a New York federal judge Wednesday, ending a class action...To view the full article, register now.
Already a subscriber? Click here to view full article